BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8633615)

  • 1. Case-control studies of screening efficacy: the use of persons newly diagnosed with cancer who later sustain an unfavorable outcome.
    Weiss NS; Lazovich D
    Am J Epidemiol; 1996 Feb; 143(4):319-22. PubMed ID: 8633615
    [No Abstract]   [Full Text] [Related]  

  • 2. Interview-based case-control studies of screening efficacy.
    Weiss NS; Bodelon C
    Epidemiology; 2008 Mar; 19(2):265-7. PubMed ID: 18277161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cancer service screening: case referent studies recommended.
    Verbeek AL; Broeders MJ
    Stat Methods Med Res; 2010 Oct; 19(5):487-505. PubMed ID: 20356858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case-control prostate cancer screening studies should not exclude subjects with lower urinary tract symptoms.
    Godley PA; Carpenter WR
    J Clin Epidemiol; 2007 Feb; 60(2):176-80. PubMed ID: 17208124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales.
    Fielder HM; Warwick J; Brook D; Gower-Thomas K; Cuzick J; Monypenny I; Duffy SW
    J Med Screen; 2004; 11(4):194-8. PubMed ID: 15563774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study.
    Faivre J; Tazi MA; El Mrini T; Lejeune C; Benhamiche AM; Dassonville F
    Br J Cancer; 1999 Feb; 79(3-4):680-3. PubMed ID: 10027349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Peters U; Leitzmann MF; Chatterjee N; Wang Y; Albanes D; Gelmann EP; Friesen MD; Riboli E; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):962-8. PubMed ID: 17507623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of self-reported family history of cancer in a large case-control study of lymphoma.
    Chang ET; Smedby KE; Hjalgrim H; Glimelius B; Adami HO
    J Natl Cancer Inst; 2006 Jan; 98(1):61-8. PubMed ID: 16391372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of screening for lung cancer in Niigata Prefecture, Japan: a population-based case-control study.
    Tsukada H; Kurita Y; Yokoyama A; Wakai S; Nakayama T; Sagawa M; Misawa H
    Br J Cancer; 2001 Nov; 85(9):1326-31. PubMed ID: 11720469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of screening for prostate cancer: a nested case-control study.
    Concato J; Wells CK; Horwitz RI; Penson D; Fincke G; Berlowitz DR; Froehlich G; Blake D; Vickers MA; Gehr GA; Raheb NH; Sullivan G; Peduzzi P
    Arch Intern Med; 2006 Jan; 166(1):38-43. PubMed ID: 16401808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthy screened bias in epidemiologic studies of cancer incidence.
    Weiss NS; Rossing MA
    Epidemiology; 1996 May; 7(3):319-22. PubMed ID: 8728451
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for cancer: evaluating the evidence.
    Gates TJ
    Am Fam Physician; 2001 Feb; 63(3):513-22. PubMed ID: 11272300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between hospitalized and screening controls in studies assessing breast cancer risk.
    Garbers S; Dubin N; Toniolo P; Wynder EL; Taioli E
    Bull Cancer; 2004 Jun; 91(6):E211-24. PubMed ID: 15562565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misclassification in case-control studies of gene-environment interactions: assessment of bias and sample size.
    Garcia-Closas M; Rothman N; Lubin J
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1043-50. PubMed ID: 10613335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
    Dorgan JF; Stanczyk FZ; Longcope C; Stephenson HE; Chang L; Miller R; Franz C; Falk RT; Kahle L
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):177-81. PubMed ID: 9138660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the effectiveness of screening for scoliosis: a case-control study.
    Bunge EM; Juttmann RE; van Biezen FC; Creemers H; Hazebroek-Kampschreur AA; Luttmer BC; Wiegersma PA; de Koning HJ;
    Pediatrics; 2008 Jan; 121(1):9-14. PubMed ID: 18166551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of design and bias issues in case-control studies of cancer screening using microsimulation.
    Connor RJ; Boer R; Prorok PC; Weed DL
    Am J Epidemiol; 2000 May; 151(10):991-8. PubMed ID: 10853638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of case-control studies of the efficacy of screening for cancer: How should we deal with tests done in persons with symptoms?
    Weiss NS
    Am J Epidemiol; 1998 Jun; 147(12):1099-102. PubMed ID: 9645787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.